Sprint Biosciences CEO Johan Emilsson appeared in an interview with BiotechTV in connection with the Swiss Nordic Bio 2026 investor conference. The conversation focused on how the company uses fragment-based drug discovery to identify and develop new small-molecule drug candidates. Watch the interview here: Biotech TV

Se intervjun här: Biotech TV